Skip to main content
Top
Published in: BMC Immunology 1/2009

Open Access 01-12-2009 | Research article

Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria

Authors: Shomik Sibartie, Ann M O'Hara, Jude Ryan, Áine Fanning, Jim O'Mahony, Shaun O'Neill, Barbara Sheil, Liam O'Mahony, Fergus Shanahan

Published in: BMC Immunology | Issue 1/2009

Login to get access

Abstract

Background

Human intestinal epithelial cells (IECs) secrete the chemokine CCL20 in response to infection by various enteropathogenic bacteria or exposure to bacterial flagellin. CCL20 recruits immature dendritic cells and lymphocytes to target sites. Here we investigated IEC responses to various pathogenic and commensal bacteria as well as the modulatory effects of commensal bacteria on pathogen-induced CCL20 secretion. HT-29 human IECs were incubated with commensal bacteria (Bifidobacterium infantis or Lactobacillus salivarius), or with Salmonella typhimurium, its flagellin, Clostridium difficile, Mycobacterium paratuberculosis, or Mycobacterium smegmatis for varying times. In some studies, HT-29 cells were pre-treated with a commensal strain for 2 hr prior to infection or flagellin stimulation. CCL20 and interleukin (IL)-8 secretion and nuclear factor (NF)-κB activation were measured using enzyme-linked immunosorbent assays.

Results

Compared to untreated cells, S. typhimurium, C. difficile, M. paratuberculosis, and flagellin activated NF-κB and stimulated significant secretion of CCL20 and IL-8 by HT-29 cells. Conversely, B. infantis, L. salivarius or M. smegmatis did not activate NF-κB or augment CCL20 or IL-8 production. Treatment with B. infantis, but not L. salivarius, dose-dependently inhibited the baseline secretion of CCL20. In cells pre-treated with B. infantis, C. difficile-, S. typhimurium-, and flagellin-induced CCL20 were significantly attenuated. B. infantis did not limit M. Paratuberculosis- induced CCL20 secretion.

Conclusion

This study is the first to demonstrate that a commensal strain can attenuate CCL20 secretion in HT-29 IECs. Collectively, the data indicate that M. paratuberculosis may mediate mucosal damage and that B. infantis can exert immunomodulatory effects on IECs that mediate host responses to flagellin and flagellated enteric pathogens.
Appendix
Available only for authorised users
Literature
1.
go back to reference Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004, 118 (2): 229-241. 10.1016/j.cell.2004.07.002.CrossRefPubMed Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004, 118 (2): 229-241. 10.1016/j.cell.2004.07.002.CrossRefPubMed
2.
go back to reference Kagnoff MF, Eckmann L: Epithelial cells as sensors for microbial infection. Clin Invest. 1997, 100 (1): 6-10. 10.1172/JCI119522.CrossRef Kagnoff MF, Eckmann L: Epithelial cells as sensors for microbial infection. Clin Invest. 1997, 100 (1): 6-10. 10.1172/JCI119522.CrossRef
3.
go back to reference Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker HC: CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005, 307 (5707): 254-258. 10.1126/science.1102901.CrossRefPubMed Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker HC: CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance. Science. 2005, 307 (5707): 254-258. 10.1126/science.1102901.CrossRefPubMed
4.
go back to reference Kelsall BL, Biron CA, Sharma O, Kaye PM: Dendritic cells at the host-pathogen interface. Nat Immunol. 2002, 3 (8): 699-702. 10.1038/ni0802-699.CrossRefPubMed Kelsall BL, Biron CA, Sharma O, Kaye PM: Dendritic cells at the host-pathogen interface. Nat Immunol. 2002, 3 (8): 699-702. 10.1038/ni0802-699.CrossRefPubMed
5.
go back to reference Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001, 2 (4): 361-367. 10.1038/86373.CrossRefPubMed Rescigno M, Urbano M, Valzasina B, Francolini M, Rotta G, Bonasio R, Granucci F, Kraehenbuhl JP, Ricciardi-Castagnoli P: Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat Immunol. 2001, 2 (4): 361-367. 10.1038/86373.CrossRefPubMed
6.
go back to reference Rescigno M: Dendritic cells and the complexity of microbial infection. Trends Microbiol. 2002, 10 (9): 425-461. 10.1016/S0966-842X(02)02425-3.CrossRefPubMed Rescigno M: Dendritic cells and the complexity of microbial infection. Trends Microbiol. 2002, 10 (9): 425-461. 10.1016/S0966-842X(02)02425-3.CrossRefPubMed
7.
go back to reference Kim CH: The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr Opin Hematol. 2005, 12 (4): 298-304. 10.1097/01.moh.0000166496.18773.e3.CrossRefPubMed Kim CH: The greater chemotactic network for lymphocyte trafficking: chemokines and beyond. Curr Opin Hematol. 2005, 12 (4): 298-304. 10.1097/01.moh.0000166496.18773.e3.CrossRefPubMed
8.
go back to reference Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 2000, 18: 217-242. 10.1146/annurev.immunol.18.1.217.CrossRefPubMed Rossi D, Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol. 2000, 18: 217-242. 10.1146/annurev.immunol.18.1.217.CrossRefPubMed
9.
go back to reference Schutyser E, Struyf S, Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003, 14 (5): 409-426. 10.1016/S1359-6101(03)00049-2.CrossRefPubMed Schutyser E, Struyf S, Van Damme J: The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003, 14 (5): 409-426. 10.1016/S1359-6101(03)00049-2.CrossRefPubMed
10.
go back to reference Crane-Godreau MA, Wira CR: Effect of Escherichia coli and Lactobacillus rhamnosus on macrophage inflammatory protein 3 alpha, tumor necrosis factor alpha, and transforming growth factor beta release by polarized rat uterine epithelial cells in culture. Infect Immun. 2004, 72 (4): 1866-1873. 10.1128/IAI.72.4.1866-1873.2004.PubMedCentralCrossRefPubMed Crane-Godreau MA, Wira CR: Effect of Escherichia coli and Lactobacillus rhamnosus on macrophage inflammatory protein 3 alpha, tumor necrosis factor alpha, and transforming growth factor beta release by polarized rat uterine epithelial cells in culture. Infect Immun. 2004, 72 (4): 1866-1873. 10.1128/IAI.72.4.1866-1873.2004.PubMedCentralCrossRefPubMed
11.
go back to reference Iwasaki A, Kelsall BL: Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med. 2000, 191 (8): 1381-1394. 10.1084/jem.191.8.1381.PubMedCentralCrossRefPubMed Iwasaki A, Kelsall BL: Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein (MIP)-3alpha, MIP-3beta, and secondary lymphoid organ chemokine. J Exp Med. 2000, 191 (8): 1381-1394. 10.1084/jem.191.8.1381.PubMedCentralCrossRefPubMed
12.
go back to reference Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, Wiekowski MT, Sullivan LM, Smith SR, Greenberg HB, Narula SK, Lipp M, Lira SA: CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 2000, 12 (5): 495-503. 10.1016/S1074-7613(00)80201-0.CrossRefPubMed Cook DN, Prosser DM, Forster R, Zhang J, Kuklin NA, Abbondanzo SJ, Niu XD, Chen SC, Manfra DJ, Wiekowski MT, Sullivan LM, Smith SR, Greenberg HB, Narula SK, Lipp M, Lira SA: CCR6 mediates dendritic cell localization, lymphocyte homeostasis, and immune responses in mucosal tissue. Immunity. 2000, 12 (5): 495-503. 10.1016/S1074-7613(00)80201-0.CrossRefPubMed
13.
go back to reference Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C: Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med. 2000, 192 (5): 705-718. 10.1084/jem.192.5.705.PubMedCentralCrossRefPubMed Dieu-Nosjean MC, Massacrier C, Homey B, Vanbervliet B, Pin JJ, Vicari A, Lebecque S, Dezutter-Dambuyant C, Schmitt D, Zlotnik A, Caux C: Macrophage inflammatory protein 3alpha is expressed at inflamed epithelial surfaces and is the most potent chemokine known in attracting Langerhans cell precursors. J Exp Med. 2000, 192 (5): 705-718. 10.1084/jem.192.5.705.PubMedCentralCrossRefPubMed
14.
go back to reference Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, Ohyanagi H, Yoshie O: Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB. Int Immunol. 2001, 13 (10): 1255-1263. 10.1093/intimm/13.10.1255.CrossRefPubMed Fujiie S, Hieshima K, Izawa D, Nakayama T, Fujisawa R, Ohyanagi H, Yoshie O: Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3alpha/CCL20 in mucosal epithelial cells through NF-kappaB. Int Immunol. 2001, 13 (10): 1255-1263. 10.1093/intimm/13.10.1255.CrossRefPubMed
15.
go back to reference Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF: Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (4): G710-719.PubMed Izadpanah A, Dwinell MB, Eckmann L, Varki NM, Kagnoff MF: Regulated MIP-3alpha/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity. Am J Physiol Gastrointest Liver Physiol. 2001, 280 (4): G710-719.PubMed
16.
go back to reference Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC: Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA. 2001, 98 (24): 13722-13727. 10.1073/pnas.241308598.PubMedCentralCrossRefPubMed Sierro F, Dubois B, Coste A, Kaiserlian D, Kraehenbuhl JP, Sirard JC: Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells. Proc Natl Acad Sci USA. 2001, 98 (24): 13722-13727. 10.1073/pnas.241308598.PubMedCentralCrossRefPubMed
17.
go back to reference Gewirtz AT, Navas TA, Lyons L, Godowski PJ, Madara JL: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol. 2001, 167: 1882-1885.CrossRefPubMed Gewirtz AT, Navas TA, Lyons L, Godowski PJ, Madara JL: Bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J Immunol. 2001, 167: 1882-1885.CrossRefPubMed
18.
go back to reference Coyne MJ, Reinap B, Lee MM, Comstock LE: Human symbionts use a host-like pathway for surface fucosylation. Science. 2005, 307 (5716): 1778-1781. 10.1126/science.1106469.CrossRefPubMed Coyne MJ, Reinap B, Lee MM, Comstock LE: Human symbionts use a host-like pathway for surface fucosylation. Science. 2005, 307 (5716): 1778-1781. 10.1126/science.1106469.CrossRefPubMed
19.
go back to reference Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2004, 5 (1): 104-112. 10.1038/ni1018.CrossRefPubMed Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AG, Pettersson S, Conway S: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat Immunol. 2004, 5 (1): 104-112. 10.1038/ni1018.CrossRefPubMed
20.
go back to reference Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000, 289 (5484): 1560-1563. 10.1126/science.289.5484.1560.CrossRefPubMed Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, Karmali V, Rao AS, Madara JL: Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 2000, 289 (5484): 1560-1563. 10.1126/science.289.5484.1560.CrossRefPubMed
21.
go back to reference Otte JM, Podolsky DK: Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004, 286 (4): G613-626. 10.1152/ajpgi.00341.2003.CrossRefPubMed Otte JM, Podolsky DK: Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol. 2004, 286 (4): G613-626. 10.1152/ajpgi.00341.2003.CrossRefPubMed
22.
go back to reference Ma D, Forsythe P, Bienenstock J: Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun. 2004, 72 (9): 5308-5314. 10.1128/IAI.72.9.5308-5314.2004.PubMedCentralCrossRefPubMed Ma D, Forsythe P, Bienenstock J: Live Lactobacillus reuteri is essential for the inhibitory effect on tumor necrosis factor alpha-induced interleukin-8 expression. Infect Immun. 2004, 72 (9): 5308-5314. 10.1128/IAI.72.9.5308-5314.2004.PubMedCentralCrossRefPubMed
23.
go back to reference O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L, Shanahan F: Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006, 118: 202-215. 10.1111/j.1365-2567.2006.02358.x.PubMedCentralCrossRefPubMed O'Hara AM, O'Regan P, Fanning A, O'Mahony C, Macsharry J, Lyons A, Bienenstock J, O'Mahony L, Shanahan F: Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius. Immunology. 2006, 118: 202-215. 10.1111/j.1365-2567.2006.02358.x.PubMedCentralCrossRefPubMed
24.
go back to reference Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK: In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001, 73 (2 Suppl): 386S-392S.PubMed Dunne C, O'Mahony L, Murphy L, Thornton G, Morrissey D, O'Halloran S, Feeney M, Flynn S, Fitzgerald G, Daly C, Kiely B, O'Sullivan GC, Shanahan F, Collins JK: In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr. 2001, 73 (2 Suppl): 386S-392S.PubMed
25.
go back to reference Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK: Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999, 76 (1-4): 279-292. 10.1023/A:1002065931997.CrossRefPubMed Dunne C, Murphy L, Flynn S, O'Mahony L, O'Halloran S, Feeney M, Morrissey D, Thornton G, Fitzgerald G, Daly C, Kiely B, Quigley EM, O'Sullivan GC, Shanahan F, Collins JK: Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 1999, 76 (1-4): 279-292. 10.1023/A:1002065931997.CrossRefPubMed
26.
go back to reference O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005, 128 (3): 541-551. 10.1053/j.gastro.2004.11.050.CrossRefPubMed O'Mahony L, McCarthy J, Kelly P, Hurley G, Luo F, Chen K, O'Sullivan GC, Kiely B, Collins JK, Shanahan F, Quigley EM: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology. 2005, 128 (3): 541-551. 10.1053/j.gastro.2004.11.050.CrossRefPubMed
27.
go back to reference McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F: Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003, 52 (7): 975-980. 10.1136/gut.52.7.975.PubMedCentralCrossRefPubMed McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F: Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut. 2003, 52 (7): 975-980. 10.1136/gut.52.7.975.PubMedCentralCrossRefPubMed
28.
go back to reference Bartlett JG: Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002, 346 (5): 334-339. 10.1056/NEJMcp011603.CrossRefPubMed Bartlett JG: Clinical practice. Antibiotic-associated diarrhea. N Engl J Med. 2002, 346 (5): 334-339. 10.1056/NEJMcp011603.CrossRefPubMed
29.
go back to reference Poxton IR, McCoubrey J, Blair G: The pathogenicity of Clostridium difficile. Clin Microbiol Infect. 2001, 7 (8): 421-427. 10.1046/j.1198-743x.2001.00287.x.CrossRefPubMed Poxton IR, McCoubrey J, Blair G: The pathogenicity of Clostridium difficile. Clin Microbiol Infect. 2001, 7 (8): 421-427. 10.1046/j.1198-743x.2001.00287.x.CrossRefPubMed
30.
go back to reference Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C: Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology. 2003, 125 (2): 413-420. 10.1016/S0016-5085(03)00902-8.CrossRefPubMed Savidge TC, Pan WH, Newman P, O'Brien M, Anton PM, Pothoulakis C: Clostridium difficile toxin B is an inflammatory enterotoxin in human intestine. Gastroenterology. 2003, 125 (2): 413-420. 10.1016/S0016-5085(03)00902-8.CrossRefPubMed
31.
go back to reference Gupta S, Chatterji D: Stress responses in mycobacteria. IUBMB Life. 2005, 57 (3): 149-159. 10.1080/15216540500090611.CrossRefPubMed Gupta S, Chatterji D: Stress responses in mycobacteria. IUBMB Life. 2005, 57 (3): 149-159. 10.1080/15216540500090611.CrossRefPubMed
32.
go back to reference Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003, 52 (6): 827-833. 10.1136/gut.52.6.827.PubMedCentralCrossRefPubMed Mack DR, Ahrne S, Hyde L, Wei S, Hollingsworth MA: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut. 2003, 52 (6): 827-833. 10.1136/gut.52.6.827.PubMedCentralCrossRefPubMed
33.
go back to reference Haller D, Holt L, Parlesak A, Zanga J, Bauerlein A, Sartor RB, Jobin C: Differential effect of immune cells on non-pathogenic Gram-negative bacteriainduced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology. 2004, 112 (2): 310-320. 10.1111/j.1365-2567.2004.01874.x.PubMedCentralCrossRefPubMed Haller D, Holt L, Parlesak A, Zanga J, Bauerlein A, Sartor RB, Jobin C: Differential effect of immune cells on non-pathogenic Gram-negative bacteriainduced nuclear factor-kappaB activation and pro-inflammatory gene expression in intestinal epithelial cells. Immunology. 2004, 112 (2): 310-320. 10.1111/j.1365-2567.2004.01874.x.PubMedCentralCrossRefPubMed
34.
go back to reference Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB: Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology. 1995, 108 (1): 65-74. 10.1016/0016-5085(95)90009-8.CrossRefPubMed Crowe SE, Alvarez L, Dytoc M, Hunt RH, Muller M, Sherman P, Patel J, Jin Y, Ernst PB: Expression of interleukin 8 and CD54 by human gastric epithelium after Helicobacter pylori infection in vitro. Gastroenterology. 1995, 108 (1): 65-74. 10.1016/0016-5085(95)90009-8.CrossRefPubMed
35.
go back to reference Jobin C, Sartor RB: The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol. 2000, 278 (3): C451-462.PubMed Jobin C, Sartor RB: The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection. Am J Physiol Cell Physiol. 2000, 278 (3): C451-462.PubMed
36.
go back to reference Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, Ishimaru T, Matsuyama T: Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J Immunol. 2002, 168 (11): 5621-5628.CrossRefPubMed Sugita S, Kohno T, Yamamoto K, Imaizumi Y, Nakajima H, Ishimaru T, Matsuyama T: Induction of macrophage-inflammatory protein-3alpha gene expression by TNF-dependent NF-kappaB activation. J Immunol. 2002, 168 (11): 5621-5628.CrossRefPubMed
37.
go back to reference Canny G, Drudy D, Macmathuna P, O'Farrelly C, Baird AW: Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical. Life Sci. 2006, 78 (9): 920-925. 10.1016/j.lfs.2005.05.102.CrossRefPubMed Canny G, Drudy D, Macmathuna P, O'Farrelly C, Baird AW: Toxigenic C. difficile induced inflammatory marker expression by human intestinal epithelial cells is asymmetrical. Life Sci. 2006, 78 (9): 920-925. 10.1016/j.lfs.2005.05.102.CrossRefPubMed
38.
go back to reference Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V: In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem. 2004, 279 (41): 42984-42992. 10.1074/jbc.M405410200.CrossRefPubMed Bambou JC, Giraud A, Menard S, Begue B, Rakotobe S, Heyman M, Taddei F, Cerf-Bensussan N, Gaboriau-Routhiau V: In vitro and ex vivo activation of the TLR5 signaling pathway in intestinal epithelial cells by a commensal Escherichia coli strain. J Biol Chem. 2004, 279 (41): 42984-42992. 10.1074/jbc.M405410200.CrossRefPubMed
39.
go back to reference Sirard JC, Didierlaurent A, Cayet D, Sierro F, Rumbo M: Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamics. Biochim Biophys Acta. 2000, 1789 (5): 386-394.CrossRef Sirard JC, Didierlaurent A, Cayet D, Sierro F, Rumbo M: Toll-like receptor 5- and lymphotoxin beta receptor-dependent epithelial Ccl20 expression involves the same NF-kappaB binding site but distinct NF-kappaB pathways and dynamics. Biochim Biophys Acta. 2000, 1789 (5): 386-394.CrossRef
40.
go back to reference Lillehoj EP, Kim H, Chun EY, Kim KC: Pseudomonas aeruginosa stimulates phosphorylation of the Epithelial Membrane Glycoprotein Muc1 and Activates MAP Kinase. Am J Physiol Lung Cell Mol Physiol. 2004, 287 (4): L809-L815. 10.1152/ajplung.00385.2003.CrossRefPubMed Lillehoj EP, Kim H, Chun EY, Kim KC: Pseudomonas aeruginosa stimulates phosphorylation of the Epithelial Membrane Glycoprotein Muc1 and Activates MAP Kinase. Am J Physiol Lung Cell Mol Physiol. 2004, 287 (4): L809-L815. 10.1152/ajplung.00385.2003.CrossRefPubMed
41.
go back to reference Tallant T, Deb A, Kar N, Lupica J, de Veer MJ, DiDonato JA: Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol. 2004, 4: 33-10.1186/1471-2180-4-33.PubMedCentralCrossRefPubMed Tallant T, Deb A, Kar N, Lupica J, de Veer MJ, DiDonato JA: Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-kappa B and proinflammatory gene program activation in intestinal epithelial cells. BMC Microbiol. 2004, 4: 33-10.1186/1471-2180-4-33.PubMedCentralCrossRefPubMed
42.
go back to reference Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC: Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002, 51 (6): 818-826. 10.1136/gut.51.6.818.PubMedCentralCrossRefPubMed Kwon JH, Keates S, Bassani L, Mayer LF, Keates AC: Colonic epithelial cells are a major site of macrophage inflammatory protein 3alpha (MIP-3alpha) production in normal colon and inflammatory bowel disease. Gut. 2002, 51 (6): 818-826. 10.1136/gut.51.6.818.PubMedCentralCrossRefPubMed
43.
go back to reference Veckman V, Miettinen M, Matikainen S, Lande R, Giacomini E, Coccia EM, Julkunen I: Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol. 2003, 74 (3): 395-402. 10.1189/jlb.0402212.CrossRefPubMed Veckman V, Miettinen M, Matikainen S, Lande R, Giacomini E, Coccia EM, Julkunen I: Lactobacilli and streptococci induce inflammatory chemokine production in human macrophages that stimulates Th1 cell chemotaxis. J Leukoc Biol. 2003, 74 (3): 395-402. 10.1189/jlb.0402212.CrossRefPubMed
44.
go back to reference Toki S, Kagaya S, Shinohara M, Wakiguchi H, Matsumoto T, Takahata Y, Morimatsu F, Saito H, Matsumoto K: Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int Arch Allergy Immunol. 2009, 148 (1): 45-58. 10.1159/000151505.CrossRefPubMed Toki S, Kagaya S, Shinohara M, Wakiguchi H, Matsumoto T, Takahata Y, Morimatsu F, Saito H, Matsumoto K: Lactobacillus rhamnosus GG and Lactobacillus casei suppress Escherichia coli-induced chemokine expression in intestinal epithelial cells. Int Arch Allergy Immunol. 2009, 148 (1): 45-58. 10.1159/000151505.CrossRefPubMed
45.
go back to reference Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM, et al.: Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. Journal of cellular Physiology. 2006, 209 (2): 241-252. 10.1002/jcp.20739.CrossRefPubMed Begue B, Dumant C, Bambou JC, Beaulieu JF, Chamaillard M, Hugot JP, Goulet O, Schmitz J, Philpott DJ, Cerf-Bensussan N, Ruemmele FM, et al.: Microbial induction of CARD15 expression in intestinal epithelial cells via toll-like receptor 5 triggers an antibacterial response loop. Journal of cellular Physiology. 2006, 209 (2): 241-252. 10.1002/jcp.20739.CrossRefPubMed
46.
go back to reference Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthesy- Theulaz IE: Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun. 2004, 72 (4): 2160-2169. 10.1128/IAI.72.4.2160-2169.2004.PubMedCentralCrossRefPubMed Granato D, Bergonzelli GE, Pridmore RD, Marvin L, Rouvet M, Corthesy- Theulaz IE: Cell surface-associated elongation factor Tu mediates the attachment of Lactobacillus johnsonii NCC533 (La1) to human intestinal cells and mucins. Infect Immun. 2004, 72 (4): 2160-2169. 10.1128/IAI.72.4.2160-2169.2004.PubMedCentralCrossRefPubMed
47.
go back to reference Chacon O, Bermudez LE, Barletta RG: Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol. 2004, 58: 329-363. 10.1146/annurev.micro.58.030603.123726.CrossRefPubMed Chacon O, Bermudez LE, Barletta RG: Johne's disease, inflammatory bowel disease, and Mycobacterium paratuberculosis. Annu Rev Microbiol. 2004, 58: 329-363. 10.1146/annurev.micro.58.030603.123726.CrossRefPubMed
48.
go back to reference O'Hara AM, Shanahan F: Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol. 2007, 5 (3): 274-284. 10.1016/j.cgh.2006.12.009.CrossRefPubMed O'Hara AM, Shanahan F: Gut microbiota: mining for therapeutic potential. Clin Gastroenterol Hepatol. 2007, 5 (3): 274-284. 10.1016/j.cgh.2006.12.009.CrossRefPubMed
49.
50.
go back to reference Shanahan F, O'Mahony J: The mycobacteria story in Crohn's disease. Am J Gastroenterol. 2005, 100 (7): 1537-1538. 10.1111/j.1572-0241.2005.50358.x.CrossRefPubMed Shanahan F, O'Mahony J: The mycobacteria story in Crohn's disease. Am J Gastroenterol. 2005, 100 (7): 1537-1538. 10.1111/j.1572-0241.2005.50358.x.CrossRefPubMed
Metadata
Title
Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria
Authors
Shomik Sibartie
Ann M O'Hara
Jude Ryan
Áine Fanning
Jim O'Mahony
Shaun O'Neill
Barbara Sheil
Liam O'Mahony
Fergus Shanahan
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2009
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-10-54

Other articles of this Issue 1/2009

BMC Immunology 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.